Bristol-Myers Squibb Company
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $5.42B | $4.24B | $2.39B | $5.57B | $3.59B | $1.66B | $5.78B | $5.03B |
| Accounts Receivable | $4.35B | $3.77B | $2.95B | $2.10B | $1.69B | $1.71B | $2.25B | $1.99B |
| Inventory | $1.17B | $1.24B | $1.22B | $1.56B | $1.50B | $1.66B | $1.38B | $1.20B |
| Total Current Assets | $14.85B | $13.70B | $10.42B | $14.61B | $18.92B | $9.52B | $15.32B | $13.27B |
| Property, Plant & Equipment | $5.00B | $4.98B | $4.41B | $4.42B | $4.58B | $5.33B | $4.52B | $4.66B |
| Goodwill | $6.86B | $6.88B | $6.88B | $7.03B | $7.10B | $7.64B | $5.59B | $5.23B |
| Intangible Assets (Excl. Goodwill) | $1.21B | $1.39B | $1.42B | $1.75B | $2.32B | $8.78B | $3.12B | $3.37B |
| Total Assets | $33.55B | $33.71B | $31.75B | $33.75B | $38.59B | $35.90B | $32.97B | $31.08B |
| Liabilities | ||||||||
| Accounts Payable | $2.25B | $1.66B | $1.57B | $2.49B | $2.56B | $2.20B | $2.60B | $1.98B |
| Total Current Liabilities | $9.56B | $8.84B | $8.02B | $8.46B | $12.44B | $8.28B | $7.78B | $6.74B |
| Long-Term Debt | $6.98B | $5.72B | $6.55B | $7.24B | $7.98B | $6.57B | $5.38B | $5.33B |
| Total Liabilities | $21.70B | $17.36B | $17.32B | $18.77B | $23.36B | $22.26B | $17.10B | $15.44B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $31.16B | $33.51B | $31.61B | $32.54B | $32.95B | $32.73B | $33.07B | $31.64B |
| Total Stockholders' Equity | $11.74B | $16.18B | $14.27B | $14.85B | $15.15B | $13.62B | $15.96B | $15.71B |